NCT00675012 2014-05-30
NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer
AGC Biologics S.p.A.
Phase 2 Completed
AGC Biologics S.p.A.
European Organisation for Research and Treatment of Cancer - EORTC